Skip to main content
BD's flow cytometer system wins FDA clearance

The FDA granted Becton Dickinson 510(k) clearance for its BD FACSLyric flow cytometer system, which is designed to be used with BD Multitest assays for use in immunological assessments of individuals with suspected or confirmed immune deficiency. The company said its system delivers repeatable and accurate results through the combination of a benchtop-sized instrument with reagents, software and services.

Full Story: